Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.19.3
Stock-based Compensation (Tables)
 9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Recognized Stock-Based Compensation

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows:

 

   

Three Months Ended

September 30,

    

Nine Months Ended

September 30,

  
    2019     2018     2019     2018  
Research and Development   $ 185     $ 101     $ 834     $ 787  
General and Administrative     486       404       1,463       2,016  
Total   $ 671     $ 505     $ 2,297     $ 2,803  

Schedule of Equity Compensation Plan by Arrangements

The following table contains information about the Company’s stock plan at September 30, 2019:

 

    Awards Reserved for Issuance     Awards Issued     Awards
Available for Grant		  
2013 Equity Compensation Plan     22,422 *     19,132 **     3,289  
                         

 

* Increased by 4,532 thousand on January 1, 2019, representing 4% of the total number of shares of common stock outstanding on December 31, 2018.
** Includes both stock grants and option grants

Schedule of Stock Option Activity

The following table summarizes the Company’ stock option activity and related information for the period from December 31, 2018 to September 30, 2019 (options in thousands):

 

    Number of Options     Weighted Average Exercise Price     Weighted Average Contractual Term in Years  
Outstanding at December 31, 2018     13,457     $ 1.13       6.2  
Granted     3,595     $ 1.03          
Exercised                        
Forfeited     (137 )   $ 1.22          
Cancelled                        
Expired     (56 )   $ 2.32          
Outstanding at September 30, 2019     16,859     $ 1.11       6.3  

Schedule of Share Based Payment Assumptions

The following weighted-average assumptions were used to calculate share-based compensation for the comparative periods presented:

 

    For the Three Months Ended     For the Nine Months Ended  
    September 30,     September 30,  
    2019     2018     2019     2018  
Volatility     108.03-108.06 %     105.85-109.95 %     108.03-111.34 %     105.85-109.95 %
Risk-free interest rate     1.59-1.89 %     2.84-3.00 %     1.59-2.65 %     2.29-3.00 %
Dividend yield     0.0 %     0.0 %     0.0 %     0.0 %
Expected life     6.0 years       6.0 years       6.0 years       6.0 years